FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33767311000001106: Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
102671901000001119 Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
102672001000001110 Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Rupatadine fumarate true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Is a Rupatadine 10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has AMP Rupatadine 10mg tablets (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Rupatadine fumarate false Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rupatadine false Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets Has basis of strength substance Rupatadine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start